Insider Stock Trading History of Emster Kurt Von


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Emster Kurt Von since year 2005. The trader's CIK number is 1252524. At the time of this reporting, Emster Kurt Von is the of Cymabay Therapeutics, Inc. . (stock ticker symbol CBAY). See this page for all insider trading activities at Cymabay Therapeutics, Inc. .

Note that in the past EMSTER KURT VON also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Emster Kurt Von since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-10 CBAY Cymabay Therapeutics, Inc. Sale 50,048 9.26 463,394
2017-11-01 CBAY Cymabay Therapeutics, Inc. Sale 4,320 9.26 39,981
2017-10-30 CBAY Cymabay Therapeutics, Inc. Sale 6,636 9.26 61,449
2017-10-31 CBAY Cymabay Therapeutics, Inc. Sale 52,573 9.27 487,351
2017-10-02 CBAY Cymabay Therapeutics, Inc. Sale 37,936 7.93 300,832
2017-10-03 CBAY Cymabay Therapeutics, Inc. Sale 70,940 7.81 554,041
2017-09-29 CBAY Cymabay Therapeutics, Inc. Sale 120,735 8.04 970,709
2017-09-28 CBAY Cymabay Therapeutics, Inc. Sale 90,389 8.15 736,670
2017-08-28 CRSP Crispr Therapeutics Ag Sale 88,011 19.79 1,741,737
2017-08-25 CRSP Crispr Therapeutics Ag Sale 14,913 19.52 291,101
2017-08-24 CRSP Crispr Therapeutics Ag Sale 7,868 19.23 151,301
2017-08-23 CRSP Crispr Therapeutics Ag Sale 7,035 18.53 130,358
2017-08-22 CRSP Crispr Therapeutics Ag Sale 10,954 18.53 202,977
2017-08-18 CRSP Crispr Therapeutics Ag Sale 1,900 18.53 35,207
2017-08-21 CRSP Crispr Therapeutics Ag Sale 1,250 18.51 23,137
2017-08-16 CRSP Crispr Therapeutics Ag Sale 20,548 19.27 395,959
2017-08-17 CRSP Crispr Therapeutics Ag Sale 13,593 18.74 254,732
2017-08-14 CRSP Crispr Therapeutics Ag Sale 29,983 19.64 588,866
2017-08-15 CRSP Crispr Therapeutics Ag Sale 25,586 19.53 499,694
2017-08-07 CRSP Crispr Therapeutics Ag Sale 15,623 18.53 289,494
2017-08-08 CRSP Crispr Therapeutics Ag Sale 19,850 18.71 371,393
2017-08-03 CRSP Crispr Therapeutics Ag Sale 47,409 17.77 842,457
2017-08-04 CRSP Crispr Therapeutics Ag Sale 3,068 18.50 56,758
2017-08-01 CRSP Crispr Therapeutics Ag Sale 264 17.50 4,620
2017-07-31 CRSP Crispr Therapeutics Ag Sale 5,248 17.51 91,871
2017-07-28 CRSP Crispr Therapeutics Ag Sale 400 17.65 7,059
2017-07-27 CRSP Crispr Therapeutics Ag Sale 40,912 17.62 721,074
2017-07-25 CRSP Crispr Therapeutics Ag Sale 9,186 17.52 160,938
2017-07-26 CRSP Crispr Therapeutics Ag Sale 23,744 17.63 418,606
2017-07-13 CRSP Crispr Therapeutics Ag Sale 33,629 16.87 567,321
2017-07-14 CRSP Crispr Therapeutics Ag Sale 36,230 16.82 609,388
2017-07-11 CRSP Crispr Therapeutics Ag Sale 14,120 16.52 233,262
2017-07-12 CRSP Crispr Therapeutics Ag Sale 17,872 16.60 296,675
2017-07-05 CRSP Crispr Therapeutics Ag Sale 4,254 16.26 69,170
2017-06-29 CRSP Crispr Therapeutics Ag Sale 11,610 16.52 191,797
2017-06-28 CRSP Crispr Therapeutics Ag Sale 31,592 17.04 538,327
2017-06-26 CRSP Crispr Therapeutics Ag Sale 48,001 16.83 807,856
2017-06-27 CRSP Crispr Therapeutics Ag Sale 33,434 17.43 582,754
2017-06-22 CRSP Crispr Therapeutics Ag Sale 1,527 16.21 24,752
2017-06-23 CRSP Crispr Therapeutics Ag Sale 30,841 16.23 500,549
2016-10-24 CRSP Crispr Therapeutics Ag Buy 56,000 14.00 784,000
2012-09-05 SOMX Somaxon Pharmaceuticals, Inc. Sale 1,367 .29 396
2010-12-02 SOMX Somaxon Pharmaceuticals, Inc. Sale 26,000 2.78 72,306
2010-04-30 SOMX Somaxon Pharmaceuticals, Inc. Sale 42,553 7.50 319,147
2007-05-14 SOMX Somaxon Pharmaceuticals, Inc. Sale 36,300 14.80 537,385
2007-05-11 SOMX Somaxon Pharmaceuticals, Inc. Sale 32,060 14.62 468,845
2007-05-10 SOMX Somaxon Pharmaceuticals, Inc. Sale 25,000 15.65 391,325
2006-09-11 SOMX Somaxon Pharmaceuticals, Inc. Sale 3,089 14.07 43,462

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Emster Kurt Von ( of Cymabay Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.